Scientific trial loss of life leads consultants to dissect Huidagene’s technique

Three months earlier than a younger boy died in Huidagene’s gene enhancing trial final yr, the corporate’s former CEO Alvin Luk offered its early information on the American Society for Gene and Cell Remedy’s Presidential Symposium, one of many discipline’s greatest levels. 

STAT requested a number of consultants in gene enhancing and muscle problems to overview video of the presentation. They got here away divided — usually starkly — on the standard of the corporate’s science and the knowledge of the strategy.

“I’m not impressed,” stated Dongsheng Duan, who has spent a decade learning gene enhancing for Duchenne on the College of Missouri, in an e mail.